A detailed history of Truist Financial Corp transactions in Insmed Inc stock. As of the latest transaction made, Truist Financial Corp holds 45,074 shares of INSM stock, worth $4.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
45,074
Previous 30,038 50.06%
Holding current value
$4.4 Million
Previous $2.07 Million 65.85%
% of portfolio
0.01%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 29, 2025

BUY
$65.25 - $83.83 $981,099 - $1.26 Million
15,036 Added 50.06%
45,074 $3.44 Million
Q4 2024

Jan 31, 2025

BUY
$66.29 - $76.63 $66,290 - $76,630
1,000 Added 3.44%
30,038 $2.07 Million
Q3 2024

Nov 13, 2024

BUY
$62.0 - $79.01 $1.42 Million - $1.81 Million
22,872 Added 370.94%
29,038 $2.12 Million
Q2 2024

Aug 20, 2024

BUY
$22.0 - $69.71 $135,652 - $429,831
6,166 New
6,166 $413,000
Q4 2020

Feb 18, 2021

BUY
$31.45 - $40.54 $246,725 - $318,036
7,845 New
7,845 $261,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $13.2B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Truist Financial Corp Portfolio

Follow Truist Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.